Experimental Hematology
Volume 38, Issue 3 , Pages 174-179 , March 2010

Extrinsic signals determine myeloid-erythroid lineage switch in MN1 leukemia

  • Michael Heuser

      Affiliations

    • Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
    • Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
    • ,
  • Gyeongsin Park

      Affiliations

    • Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
    • ,
  • Yeonsook Moon

      Affiliations

    • Department of Laboratory Medicine, British Columbia Cancer Agency, Vancouver, BC, Canada
    • ,
  • Tobias Berg

      Affiliations

    • Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
    • ,
  • Ping Xiang

      Affiliations

    • Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
    • ,
  • Florian Kuchenbauer

      Affiliations

    • Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
    • ,
  • Sarah Vollett

      Affiliations

    • Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
    • ,
  • Courteney Lai

      Affiliations

    • Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
    • ,
  • R. Keith Humphries

      Affiliations

    • Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
    • Department of Medicine, University of British Columbia, Vancouver, BC, Canada
    • Corresponding Author InformationOffprint requests to: R. Keith Humphries, M.D., Ph.D., Terry Fox Laboratory, British Columbia Cancer Agency, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada

Received 29 December 2009 ,Revised 29 December 2009 ,Accepted 6 January 2010.

References 

  1. Wei J, Wunderlich M, Fox C, et al. Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia. Cancer Cell. 2008;13:483–495
  2. Broudy VC. Stem cell factor and hematopoiesis. Blood. 1997;90:1345–1364
  3. Russell ES, Lawson FA. Selection and inbreeding for longevity of a lethal type. J Hered. 1959;50:19–25
  4. Nocka K, Tan JC, Chiu E, et al. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J. 1990;9:1805–1813
  5. Geissler EN, Russell ES. Analysis of the hematopoietic effects of new dominant spotting (W) mutations of the mouse. I. Influence upon hematopoietic stem cells. Exp Hematol. 1983;11:452–460
  6. Lisovsky M, Braun SE, Ge Y, et al. Flt3-ligand production by human bone marrow stromal cells. Leukemia. 1996;10:1012–1018
  7. Rasko JE, Metcalf D, Rossner MT, Begley CG, Nicola NA. The flt3/flk-2 ligand: receptor distribution and action on murine haemopoietic cell survival and proliferation. Leukemia. 1995;9:2058–2066
  8. McKenna HJ, Stocking KL, Miller RE, et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood. 2000;95:3489–3497
  9. Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemischka IR. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity. 1995;3:147–161
  10. Heuser M, Argiropoulos B, Kuchenbauer F, et al. MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML. Blood. 2007;110:1639–1647
  11. Heuser M, Beutel G, Krauter J, et al. High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. Blood. 2006;108:3898–3905
  12. Kandilci A, Grosveld GC. Reintroduction of CEBPA in MN1-overexpressing hematopoietic cells prevents their hyper proliferation and restores myeloid differentiation. Blood. 2009;114:1596–1606
  13. Schambach A, Wodrich H, Hildinger M, Bohne J, Krausslich HG, Baum C. Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors. Mol Ther. 2000;2:435–445
  14. Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J. 1998;17:3714–3725
  15. Heuser M, Sly LM, Argiropoulos B, et al. Modelling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal. Blood. 2009;114:3983–3993
  16. Heuser M, Yap DB, Leung M, et al. Loss of MLL5 results in pleiotropic hematopoietic defects, reduced neutrophil immune function, and extreme sensitivity to DNA demethylation. Blood. 2009;113:1432–1443
  17. Carella C, Bonten J, Sirma S, et al. MN1 overexpression is an important step in the development of inv(16) AML. Leukemia. 2007;21:1679–1690
  18. Pineault N, Abramovich C, Humphries RK. Transplantable cell lines generated with NUP98-Hox fusion genes undergo leukemic progression by Meis1 independent of its binding to DNA. Leukemia. 2005;19:636–643
  19. Barabe F, Kennedy JA, Hope KJ, Dick JE. Modeling the initiation and progression of human acute leukemia in mice. Science. 2007;316:600–604
  20. Germano G, Pigazzi M, del Giudice L, et al. Two consecutive immunophenotypic switches in a child with MLL-rearranged acute lymphoblastic leukemia. Haematologica. 2006;91:ECR09
  21. Ridge SA, Cabrera ME, Ford AM, et al. Rapid intraclonal switch of lineage dominance in congenital leukaemia with a MLL gene rearrangement. Leukemia. 1995;9:2023–2026
  22. Broske AM, Vockentanz L, Kharazi S, et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat Genet. 2009;41:1207–1215

PII: S0301-472X(10)00011-1

doi: 10.1016/j.exphem.2010.01.003

Experimental Hematology
Volume 38, Issue 3 , Pages 174-179 , March 2010

Article Tools

* Image Usage & Resolution